Figure 2.

Simulated changes in tumor size over 1 year in the average patient treated continuously with either placebo or everolimus (5 or 10 mg daily).

Stein et al. BMC Cancer 2012 12:311   doi:10.1186/1471-2407-12-311
Download authors' original image